$2.54 Billion is the total value of BVF INC/IL's 68 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 35.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OLMA | New | OLEMA PHARMACEUTICALS INC | $320,285,000 | – | 6,661,503 | +100.0% | 12.60% | – |
| XOMA | XOMA CORP DEL | $184,562,000 | +134.2% | 4,182,243 | 0.0% | 7.26% | +69.2% | |
| KYMR | KYMERA THERAPEUTICS INC | $163,101,000 | +91.9% | 2,630,658 | 0.0% | 6.42% | +38.6% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $127,720,000 | -11.2% | 3,073,147 | -9.0% | 5.02% | -35.9% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $109,587,000 | +49.9% | 2,768,049 | +31.7% | 4.31% | +8.3% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $101,946,000 | +8.1% | 2,972,191 | -3.0% | 4.01% | -21.9% |
| MRUS | Buy | MERUS N V | $101,772,000 | +50.2% | 5,805,571 | +2.8% | 4.00% | +8.5% |
| CYTK | Buy | CYTOKINETICS INC | $101,366,000 | +40.9% | 4,878,035 | +46.8% | 3.99% | +1.8% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $86,156,000 | +85.8% | 4,273,588 | +80.1% | 3.39% | +34.2% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $77,147,000 | +121.2% | 1,364,461 | +85.6% | 3.04% | +59.7% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $71,448,000 | +60.5% | 2,752,222 | +6.0% | 2.81% | +16.0% |
| XNCR | Sell | XENCOR INC | $55,181,000 | -31.2% | 1,264,754 | -38.8% | 2.17% | -50.3% |
| XENE | XENON PHARMACEUTICALS INC | $53,820,000 | +38.9% | 3,499,346 | 0.0% | 2.12% | +0.3% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $52,624,000 | +1036.3% | 10,761,593 | +878.3% | 2.07% | +721.4% |
| ACIU | Sell | AC IMMUNE SA | $50,752,000 | +5.9% | 9,816,658 | -0.0% | 2.00% | -23.5% |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $46,620,000 | +93.3% | 540,837 | -15.4% | 1.83% | +39.7% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $45,847,000 | – | 1,106,070 | +100.0% | 1.80% | – |
| IDYA | IDEAYA BIOSCIENCES INC | $45,175,000 | +11.5% | 3,226,769 | 0.0% | 1.78% | -19.5% | |
| EPIX | Buy | ESSA PHARMA INC | $44,204,000 | +113.1% | 3,705,289 | +23.3% | 1.74% | +53.9% |
| SPRO | Buy | SPERO THERAPEUTICS INC | $43,497,000 | +189.9% | 2,243,278 | +66.9% | 1.71% | +109.4% |
| KURA | Sell | KURA ONCOLOGY INC | $40,691,000 | -10.8% | 1,245,912 | -16.3% | 1.60% | -35.6% |
| STRO | Sell | SUTRO BIOPHARMA INC | $40,254,000 | +29.7% | 1,854,162 | -39.9% | 1.58% | -6.3% |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $37,493,000 | – | 10,963,000 | +100.0% | 1.48% | – |
| INFI | INFINITY PHARMACEUTICALS INC | $36,945,000 | +81.2% | 17,426,968 | 0.0% | 1.45% | +30.9% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $36,526,000 | +54.3% | 5,576,471 | +56.7% | 1.44% | +11.5% |
| GLYC | Buy | GLYCOMIMETICS INC | $35,886,000 | +61.4% | 9,544,262 | +31.7% | 1.41% | +16.6% |
| FBRX | Sell | FORTE BIOSCIENCES INC | $26,171,000 | -30.6% | 718,788 | -7.6% | 1.03% | -49.9% |
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $25,493,000 | +41.6% | 750,000 | 0.0% | 1.00% | +2.3% | |
| VSTM | Buy | VERASTEM INC | $23,816,000 | +83.1% | 11,180,994 | +4.0% | 0.94% | +32.3% |
| IMVT | Sell | IMMUNOVANT INC | $23,759,000 | -43.7% | 514,370 | -57.1% | 0.94% | -59.3% |
| CTIC | CTI BIOPHARMA CORP | $22,314,000 | +49.8% | 6,929,690 | 0.0% | 0.88% | +8.3% | |
| CALA | Sell | CALITHERA BIOSCIENCES INC | $21,414,000 | +35.4% | 4,361,238 | -4.9% | 0.84% | -2.3% |
| MTEM | MOLECULAR TEMPLATES INC | $20,180,000 | -14.0% | 2,149,057 | 0.0% | 0.79% | -37.9% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $19,538,000 | -46.4% | 878,524 | -64.4% | 0.77% | -61.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $18,378,000 | -58.7% | 62,491 | -63.2% | 0.72% | -70.2% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $17,668,000 | -53.1% | 1,038,678 | -87.0% | 0.70% | -66.1% |
| COGT | New | COGENT BIOSCIENCES INC | $17,208,000 | – | 1,532,282 | +100.0% | 0.68% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $13,736,000 | +20.8% | 5,494,582 | 0.0% | 0.54% | -12.8% | |
| RACA | Sell | THERAPEUTICS ACQUISITION COR | $13,322,000 | -7.4% | 954,996 | -4.5% | 0.52% | -33.1% |
| NVUS | New | NOVUS THERAPEUTICS INC | $11,754,000 | – | 763,279 | +100.0% | 0.46% | – |
| GMDA | Sell | GAMIDA CELL LTD | $11,273,000 | +26.7% | 1,343,667 | -37.3% | 0.44% | -8.7% |
| MEIP | Sell | MEI PHARMA INC | $10,690,000 | -16.0% | 4,049,162 | -0.8% | 0.42% | -39.2% |
| GRTS | New | GRITSTONE ONCOLOGY INC | $10,620,000 | – | 2,695,418 | +100.0% | 0.42% | – |
| OVID | Buy | OVID THERAPEUTICS INC | $10,446,000 | -49.8% | 4,522,051 | +24.8% | 0.41% | -63.7% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $10,014,000 | -52.3% | 3,304,963 | -60.9% | 0.39% | -65.5% |
| GNCA | GENOCEA BIOSCIENCES INC | $9,710,000 | +5.7% | 4,012,404 | 0.0% | 0.38% | -23.6% | |
| BCTG | BCTG ACQUISITION CORP | $9,152,000 | +10.4% | 800,000 | 0.0% | 0.36% | -20.2% | |
| CFRX | CONTRAFECT CORP | $8,080,000 | -4.4% | 1,600,000 | 0.0% | 0.32% | -30.9% | |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $7,479,000 | -30.3% | 3,739,704 | -0.7% | 0.29% | -49.7% |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $6,920,000 | -1.0% | 1,943,712 | +11.5% | 0.27% | -28.6% |
| ERYP | ERYTECH PHARMAsponsored adr | $6,119,000 | +56.7% | 625,000 | 0.0% | 0.24% | +13.1% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $5,597,000 | -11.9% | 1,799,694 | 0.0% | 0.22% | -36.4% | |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $5,330,000 | – | 500,000 | +100.0% | 0.21% | – |
| FLACU | New | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $5,205,000 | – | 500,000 | +100.0% | 0.20% | – |
| CRIS | Sell | CURIS INC | $5,135,000 | +20.2% | 626,945 | -82.8% | 0.20% | -13.3% |
| XFOR | X4 PHARMACEUTICALS INC | $5,098,000 | -5.0% | 792,892 | 0.0% | 0.20% | -31.2% | |
| FVAM | New | 5 01 ACQUISITION CORP | $5,085,000 | – | 500,000 | +100.0% | 0.20% | – |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $5,009,000 | -57.6% | 150,787 | -53.2% | 0.20% | -69.4% |
| FWP | FORWARD PHARMA A/Ssponsord ads new | $4,557,000 | +13.0% | 647,299 | 0.0% | 0.18% | -18.6% | |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $4,558,000 | +175.6% | 3,376,207 | +4.9% | 0.18% | +98.9% |
| SNSS | SUNESIS PHARMACEUTICALS INC | $3,437,000 | +59.2% | 1,727,308 | 0.0% | 0.14% | +14.4% | |
| JYAC | New | JIYA ACQUISITION CORP | $3,090,000 | – | 300,000 | +100.0% | 0.12% | – |
| RZLT | New | REZOLUTE INC | $2,357,000 | – | 190,814 | +100.0% | 0.09% | – |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $1,062,000 | – | 100,000 | +100.0% | 0.04% | – |
| FSTX | New | F-STAR THERAPEUTICS INC | $255,000 | – | 25,844 | +100.0% | 0.01% | – |
| MGEN | New | MIRAGEN THERAPEUTICS INC | $160,000 | – | 9,747 | +100.0% | 0.01% | – |
| PANAU | Sell | PANACEA ACQUISITION CORPunit 99/99/9999 | $126,000 | -98.7% | 9,837 | -98.8% | 0.01% | -99.0% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $4,000 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
| EXEL | Exit | EXELIXIS INC | $0 | – | -15,300 | -100.0% | -0.02% | – |
| SBPH | Exit | SPRING BK PHARMACEUTICALS IN | $0 | – | -941,171 | -100.0% | -0.07% | – |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -1,686,375 | -100.0% | -0.15% | – |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -3,515,873 | -100.0% | -0.18% | – |
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -1,300,000 | -100.0% | -0.37% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -1,227,405 | -100.0% | -0.99% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -1,691,834 | -100.0% | -2.12% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -3,066,797 | -100.0% | -2.48% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.